Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRLD · against 1,372 other Healthcare companies
Ranked #570 of 1,373 · scores higher than 59% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 50–59, including PRLD · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PRLD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.13× | 0.24× | 63% | 33% | |
| BetaLower is better · 1,320 reported | 0.96 | 0.53 | 26% | 33% | |
| Current ratioHigher is better · 1,338 reported | 4.07× | 2.62× | 67% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 566 | 14.0B CNY (≈$2.0B) | 59 | 40 | |
| 567 | 2.1B CNY (≈$295M) | 59 | 39 | |
| 568 | 40.7B TRY (≈$1.2B) | 59 | 74 | |
| 569 | 327M USD | 59 | 40 | |
| 570 | 302M USD | 59 | 42 | |
| 571 | 37.3B JPY (≈$254M) | 58 | 66 | |
| 572 | 660M USD | 58 | 43 | |
| 573 | 23M USD | 58 | ||
| 574 | 775M USD | 58 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score